{"name":"Heron Therapeutics","slug":"heron-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":12429000,"netIncome":-20195000,"cash":255877000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"HTX-011","genericName":"HTX-011","slug":"htx-011","indication":"Other","status":"marketed"},{"name":"SUSTOL","genericName":"SUSTOL","slug":"sustol","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"HTX-011","genericName":"HTX-011","slug":"htx-011","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SUSTOL","genericName":"SUSTOL","slug":"sustol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"date":"2026-04-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-27","type":"earnings","source":"simplywall.st","summary":"Heron Therapeutics (HRTX) TTM Loss Of US$20.2 Million Tests Profitability Turnaround Narrative - simplywall.st","headline":"Heron Therapeutics (HRTX) TTM Loss Of US$20.2 Million Tests Profitability Turnaround Narrative","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNbVdJUnl2OC11U2lXTUJZaDR1ekVWVkJ4N0dnUFNBUGdCYlJZU1RkQTdlQk9aZkdseWtiMGw2MjZKdjVkUVktVVpfNkZ4S1hSOUNOQ3Z5UzlMR0I4Y1RBQmxKWS1CWU1XSkUzTmZTVzNIeE1UeVYxU0lxd3RVZjg2Z1poLW1VZmlNYTVWdlFoUkIwMjNMUVIyUlk1MDNtZ283djY1cm4yS2FOTTBGNUU2cERrU0xoQ1BG?oc=5","date":"2026-02-17","type":"pipeline","source":"Stock Titan","summary":"Heron Therapeutics sets Feb. 26 webcast on 2025 results, business updates - Stock Titan","headline":"Heron Therapeutics sets Feb. 26 webcast on 2025 results, business updates","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-12","type":"pipeline","source":"simplywall.st","summary":"Here's Why Heron Therapeutics (NASDAQ:HRTX) Has A Meaningful Debt Burden - simplywall.st","headline":"Here's Why Heron Therapeutics (NASDAQ:HRTX) Has A Meaningful Debt Burden","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-05","type":"pipeline","source":"simplywall.st","summary":"Market Sentiment Around Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) - simplywall.st","headline":"Market Sentiment Around Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQbXRpQWwzaGtQU05vOU0wMjdNRjNLMHVRZUJRX2RDdHVvSE4yYklLTzEzUGdwcmVsMXZuZ1JlWXRiMXBSekpMOXBLMXE5VXdYS2FVQlVHMGdGSmZVc2dOenJwTV81YmZxSzg3N1pZblh1QXJ4Rm1vVWVIVGt3enN0RTBUMk5GRWM?oc=5","date":"2025-11-04","type":"earnings","source":"Yahoo Finance","summary":"Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance","headline":"Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPWXEycl9rVDRXM2tfMWIzS3Bnb2cxUVlXQlZlMzJfbDJSbm9WVjVwb25LQWVNN2lNY3NqWENCRndZWUVSVkhFZUIycmM1dGxEQWJiREpvdUVIdW9IMWVhY3lESXJJbjR5eFdENnMwMnZ6TWdmdUtLTmFGZzlNaU5JNVJTV0REQ01HbG1QV1ZDQmtjcmhpeUV2cnFMei1raF82eTRyczRiaEk?oc=5","date":"2025-08-29","type":"pipeline","source":"The Business Journals","summary":"Cary's Fenton lands public company's HQ. What they'll pay for rent. - The Business Journals","headline":"Cary's Fenton lands public company's HQ. What they'll pay for rent.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQTFBxb2pnT0c1OXg2LWQtY1A4UEVIaEd6NWZfd2p4eXBPZ0UtVkpQN1FxQkQzTlE0TjBPclUyUEY0aHRBem01SlYwcmpfM0Eycld0M0x6eE5ydVpQWDZDNjVqazlaZ2h3SndzVGR6bm54YUlIZWFPWlZHMWFDSm9DX2ZEVHM5VTRzT0syaWEzOFdzVWp5NElMaDVqV2dtTC1UOHJKZTFOQ0pVcUtoYkxuX2dfRGFENGZyMXZTeG5ncTVCRVBtcWowWk9hZWhFWFVNRWF6bS1OTXdKdlQ2Zmc?oc=5","date":"2025-08-08","type":"earnings","source":"PR Newswire","summary":"Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress - PR Newswire","headline":"Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQWEJzR3FiWE9yZXRYMG9MaU5rQjYyRV9IbnhQeldRUUFLSE1fSUhxdjZKMGE0eC1QNm9zcWxjNUs2VmtkbXZ0LUMzSG9VLVhhdXBxSTNqT2Y2OHlzY3Q4OHJjXzl1Mm14LXd6UklXbTNvR2NiQkloSTAxODFSSHpMS24zYVdNYnVld1hHaXUzNEw0N3BZaUdsTGdKVi0?oc=5","date":"2025-08-08","type":"pipeline","source":"Yahoo Finance","summary":"Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile - Yahoo Finance","headline":"Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPUFNrWVJLa1lVM0RyWG1RNjNDOURHb1VHNWt5alB3TUZYaHFhTGlVQU1LZHJ3RkNtZXZNa0htYjl4UE5zeVByVEl1WFpCOFlvTUZVTzFlZ0hVZW5zcjRKOUJ3LWFPYkVKU3BDcHNOVV9HMXliZjBtU3R0T3lhQ3d4UVVGZHltT1NPZlFHZkJnSmdidjFia1BkS0pkV3RSVk13RVRGLU42WmFxY0xocllGeWl5ZFVmbXItb3FkblV3blJBRDk4T1RmakkybUZwQ2E4YkVuTkxB?oc=5","date":"2025-05-06","type":"earnings","source":"Investing.com","summary":"Earnings call transcript: Heron Therapeutics beats Q1 2025 expectations, stock surges - Investing.com","headline":"Earnings call transcript: Heron Therapeutics beats Q1 2025 expectations, stock surges","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxNYmpqVU1PTWgtRjZNNXFxYmcxYkg5WWdpQ0hqVmpNMjc3Rnp4ODJ4Y01YQVA0VlFZbXlvRXI5aXJoQV9YWUdESmhmWDdtbHB5V29RZ1J2Tng3dFVUUlpFVzJ1OHBZNnhQTmhoZy1MSVUzQ1J0TFdCYXJ2Yk1XMnRvU2hIa0Zpa2hTaTZwQzhLZFJORG02TWRrNXgzVzlUTkozaGlMbXVxY05MVnE0SnRNN3hRY1dnNGR1SmZhbWF2VkZ6QzI0VU11VFJjNTE3R2V2MTY5NlBR?oc=5","date":"2025-04-28","type":"pipeline","source":"PR Newswire","summary":"Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer - PR Newswire","headline":"Heron Therapeutics Announces Appointment of Mark Hensley as Chief Operating Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNVE02b08yTFBBM04za2VaempBS01yX1ExbEdVSGFPODJidHhtX08tZW5FZ1A0VE03LVppekhVdl9VQzlmdEJuMDBVZ01pSHRfQXlFNEFmb1VGVFUyVldITFZuaHMyYWV0ci1tdDJZMFF4bHd6UFEzaDc5R3JtdmZPOGJBV09jQXF2bGtON2lGUjFNZV9POVNiY2FFSEpUUm56VHdxMUV5dXZCNjh6LTZzNHBPNG1vSXpfZW9DUlA0U2RybzB5?oc=5","date":"2024-12-27","type":"pipeline","source":"Times of San Diego","summary":"San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina - Times of San Diego","headline":"San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPRzlWekNNVHpHa0pkdDFVaGQxeGs4eERUdUhZY3NuMTBrVFRxTks2X3VGb0Nmcnk3QVBoa1ZiTTdwSlhjbW1GdUZOMXdid2I0RmExZXFkc1pWcS1JNXRiQjBwQ3p2Slp5RldmeFhhQnE1c3N5cDZWVUdJaGZxQ3FCdDlpRTdYX1FCakJQTlE2VHJ5SjVMYWVQbnU3R0dWTW9kN1Y4S2JCVW5nNlZYWG5F?oc=5","date":"2024-09-03","type":"pipeline","source":"Contract Pharma","summary":"Heron Therapeutics Taps Brett Fleshman as Chief Business Officer - Contract Pharma","headline":"Heron Therapeutics Taps Brett Fleshman as Chief Business Officer","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":12429000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-20195000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":255877000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}